144 related articles for article (PubMed ID: 3875390)
1. Transient neurologic disturbances induced by high-dose methotrexate treatment.
Jaffe N; Takaue Y; Anzai T; Robertson R
Cancer; 1985 Sep; 56(6):1356-60. PubMed ID: 3875390
[TBL] [Abstract][Full Text] [Related]
2. Transient neurological disturbances induced by the chemotherapy of high-dose methotrexate for osteogenic sarcoma.
Kiu MC; Liaw CC; Yang TS; Lai GM; Hsi SN; Lu CS
Anticancer Drugs; 1994 Aug; 5(4):480-2. PubMed ID: 7949255
[TBL] [Abstract][Full Text] [Related]
3. [Evaluation of severe side effects of high-dose methotrexate in osteosarcoma].
Umeda T; Takada N; Hodaka E; Endoh F; Ishii T
Gan To Kagaku Ryoho; 1984 Feb; 11(2):285-94. PubMed ID: 6582805
[TBL] [Abstract][Full Text] [Related]
4. [Management of the administration of leucovorin calcium in high-dose methotrexate therapy].
Kickinger W; Ritschl P; Kotz R
Arzneimittelforschung; 1989 Jun; 39(6):728-31. PubMed ID: 2789050
[TBL] [Abstract][Full Text] [Related]
5. Substitution of l-leucovorin for d,l-leucovorin in the rescue from high-dose methotrexate treatment in patients with osteosarcoma.
Jaffe N; Jorgensen K; Robertson R; George M; Letvak L; Barrett G
Anticancer Drugs; 1993 Oct; 4(5):559-64. PubMed ID: 8292813
[TBL] [Abstract][Full Text] [Related]
6. High-dose methotrexate with citrovorum factor rescue and adriamycin in childhood osteogenic sarcoma.
Rosen G; Suwansirikul S; Kwon C; Tan C; Wu SJ; Beattie EJ; Murphy ML
Cancer; 1974 Apr; 33(4):1151-63. PubMed ID: 4544836
[No Abstract] [Full Text] [Related]
7. "Single"-agent activity of high-dose methotrexate with citrovorum factor rescue.
Von Hoff DD; Rozencweig M; Louie AC; Bender RA; Muggia FM
Cancer Treat Rep; 1978 Feb; 62(2):233-5. PubMed ID: 305823
[No Abstract] [Full Text] [Related]
8. Progress report on high-dose methotrexate (NSC-740) with citrovorum rescue in the treatment of metastatic bone tumors.
Jaffe N
Cancer Chemother Rep; 1974; 58(2):275-80. PubMed ID: 4598245
[No Abstract] [Full Text] [Related]
9. High-dose methotrexate for osteosarcoma: toxicity and clinical results.
Breithaupt H; Küenzlen E
Oncology; 1983; 40(2):85-9. PubMed ID: 6600827
[TBL] [Abstract][Full Text] [Related]
10. Weekly high-dose methotrexate-citrovorum factor in osteogenic sarcoma: pre-surgical treatment of primary tumor and of overt pulmonary metastases.
Jaffe N; Frei E; Traggis D; Watts H
Cancer; 1977 Jan; 39(1):45-50. PubMed ID: 299828
[TBL] [Abstract][Full Text] [Related]
11. Safety and efficacy of l-leucovorin rescue following high-dose methotrexate for osteosarcoma.
Goorin A; Strother D; Poplack D; Letvak LA; George M; Link M
Med Pediatr Oncol; 1995 Jun; 24(6):362-7. PubMed ID: 7715542
[TBL] [Abstract][Full Text] [Related]
12. High-dose methotrexate with a safe rescue program.
Decker DA; Edmonson JH; Gilchrist GS; Kovach JS; Offord JR; Taylor WF
Oncology; 1981; 38(5):262-4. PubMed ID: 6973732
[TBL] [Abstract][Full Text] [Related]
13. [The influence of liver and renal functions on the changes in serum methotrexate (MTX) level in high-dose MTX therapy].
Sato T; Nakanishi K; Takahashi M; Sato K; Miura T; Kuzuya T; Mizuno M
Gan To Kagaku Ryoho; 1990 Dec; 17(12):2375-9. PubMed ID: 2260874
[TBL] [Abstract][Full Text] [Related]
14. Comparison of intra-arterial cis-diamminedichloroplatinum II with high-dose methotrexate and citrovorum factor rescue in the treatment of primary osteosarcoma.
Jaffe N; Robertson R; Ayala A; Wallace S; Chuang V; Anzai T; Cangir A; Wang YM; Chen T
J Clin Oncol; 1985 Aug; 3(8):1101-4. PubMed ID: 3874932
[TBL] [Abstract][Full Text] [Related]
15. Plasma phenylalanine: tyrosine ratios during high-dose methotrexate-citrovorum "rescue".
Hilton MA; Patel CC; Bertolone SJ; Kmetz DR; Clark LW
Med Pediatr Oncol; 1982; 10(4):389-95. PubMed ID: 6981054
[TBL] [Abstract][Full Text] [Related]
16. [The effect of methotrexate pharmacokinetics and of leucovorin rescue on the prognosis of osteosarcoma].
Graf N; Jost W; Müller J; Keller HE; Sitzmann FC
Klin Padiatr; 1990; 202(5):340-6. PubMed ID: 2214594
[TBL] [Abstract][Full Text] [Related]
17. [Studies on the effect of high-dose methotrexate-citrovorum factor treatment for 89Sr induced osteosarcoma in mice (author's transl)].
Nakamura T
Nihon Seikeigeka Gakkai Zasshi; 1982 Feb; 56(2):149-61. PubMed ID: 6978919
[TBL] [Abstract][Full Text] [Related]
18. Favorable response of metastatic osteogenic sarcoma to pulse high-dose methotrexate with citrovorum rescue and radiation therapy.
Jaffe N; Paed D; Farber S; Traggis D; Geiser C; Kim BS; Das L; Frauenberger G; Djerassi I; Cassady JR
Cancer; 1973 Jun; 31(6):1367-73. PubMed ID: 4541163
[No Abstract] [Full Text] [Related]
19. [Effects of hydration on plasma concentrations of methotrexate in patients with osteosarcoma treated with high doses of methotrexate].
Ferrari S; Orlandi M; Avella M; Caldora P; Ferraro A; Ravazzolo G; Bacci G
Minerva Med; 1992 May; 83(5):289-93. PubMed ID: 1589134
[TBL] [Abstract][Full Text] [Related]
20. Experimental studies on high-dose methotrexate with citrovorum factor chemotherapy for 89Sr-induced osteosarcoma murine model.
Tomita K
Jpn J Antibiot; 1986 May; 39(5):1219-27. PubMed ID: 3489843
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]